The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: Regulation of steroid biosynthesis
Open Access
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (12) , 1417-1423
- https://doi.org/10.1016/s0028-3908(11)80011-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brainNeuropharmacology, 1990
- Isolation and Characterization of a Rat Brain Triakontatetraneuropeptide, a Posttranslational Product of Diazepam Binding Inhibitor: Specific Action at the Ro 5‐4864 Recognition SiteJournal of Neurochemistry, 1989
- Importance of a novel GABAA receptor subunit for benzodiazepine pharmacologyNature, 1989
- The regulation of GABAergic receptors by a novel family of endogenous neuropeptidesLife Sciences, 1987
- The stimulation of steroidogenesis by corticotrophin: the role of intracellular regulatory peptides and proteinsJournal of Endocrinology, 1987
- ACTH regulation of cholesterol movement in isolated adrenal cellsJournal of Steroid Biochemistry, 1987
- Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolismTrends in Pharmacological Sciences, 1986
- Transduction of acth signal from plasma membrane to mitochondria in adrenocortical steroidogenesis. Effects of peptide, phospholipid, and calciumJournal of Steroid Biochemistry, 1986
- Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamideLife Sciences, 1983
- Molecular Mechanisms in the Receptor Action of BenzodiazepinesAnnual Review of Pharmacology and Toxicology, 1979